Biotech engineering · Est. 2019
Engineering living systems.
We design biology the way engineers design machines — specified, simulated, built and tested in tight loops. Our platforms turn cells, enzymes and tissue into programmable components.
Platform
Four systems. One design loop.
CHORUS-9
Programmable cell-free protein synthesis. Express and test 9,216 variants per run without living cells.
Learn more →Lumenfold
AI-guided enzyme design. Generate, rank and stabilise sequences against your process conditions.
Learn more →VitraGraft
Bioprinted vascular scaffold that remodels into native tissue after implantation.
Learn more →Sentinel
Engineered probiotic biosensor that reports gut inflammation markers in real time.
Learn more →Specify
Design
Build
Measure
Leadership
The team behind the loop
Martin Haverkamp
Chief Executive Officer & Co-founder
Dr. Marisol Ortega
Chief Scientific Officer & Co-founder
Lorenzo Castellano
Chief Financial Officer
Daniel Chen
VP, Bioprocess Engineering
Newsroom
Latest
Vitralis closes $180M Series C to scale the design loop
Round led by Halcyon Ridge Capital with participation from Northfen Ventures and Lanternway Partners.
CHORUS-9 opens to early-access partners
Twelve partner labs begin running cell-free expression at 9,216 variants per run.
Kestrel Bay pilot plant begins continuous operation
The 20,000 L continuous fermentation line is now producing reagent enzymes for CHORUS-9.